These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 21592993)
1. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993 [TBL] [Abstract][Full Text] [Related]
2. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin. Rallón NI; Soriano V; Naggie S; Restrepo C; Goldstein D; Vispo E; McHutchison J; Benito JM AIDS; 2011 May; 25(8):1025-33. PubMed ID: 21505315 [TBL] [Abstract][Full Text] [Related]
3. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. Rallón NI; Naggie S; Benito JM; Medrano J; Restrepo C; Goldstein D; Shianna KV; Vispo E; Thompson A; McHutchison J; Soriano V AIDS; 2010 May; 24(8):F23-9. PubMed ID: 20389235 [TBL] [Abstract][Full Text] [Related]
4. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308 [TBL] [Abstract][Full Text] [Related]
5. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin. Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection. Kitson MT; George J; Dore GJ; Leung R; Button P; McCaughan GW; Grawford DH; Siebert W; Weltman MD; Cheng WS; Roberts SK J Gastroenterol Hepatol; 2014; 29(7):1458-62. PubMed ID: 25587616 [TBL] [Abstract][Full Text] [Related]
7. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972 [TBL] [Abstract][Full Text] [Related]
8. Influence of hepatitis C virus and IL28B genotypes on liver stiffness. Lundbo LF; Clausen LN; Weis N; Schønning K; Rosenørn L; Benfield T; Christensen PB PLoS One; 2014; 9(12):e115882. PubMed ID: 25545640 [TBL] [Abstract][Full Text] [Related]
9. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692 [TBL] [Abstract][Full Text] [Related]
10. Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection. Di Lello FA; Caruz A; Rallon NI; Rivero-Juarez A; Neukam K; Barreiro P; Camacho A; García-Rey S; Rivero A; Soriano V; Cifuentes C; Macias J; Pineda JA Eur J Clin Microbiol Infect Dis; 2013 Nov; 32(11):1427-35. PubMed ID: 23715768 [TBL] [Abstract][Full Text] [Related]
11. Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Pineda JA; Caruz A; Rivero A; Neukam K; Salas I; Camacho A; Palomares JC; Mira JA; Martínez A; Roldán C; de la Torre J; Macías J Clin Infect Dis; 2010 Oct; 51(7):788-95. PubMed ID: 20804372 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis. de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168 [TBL] [Abstract][Full Text] [Related]
13. Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection. Ydreborg M; Westin J; Rembeck K; Lindh M; Norrgren H; Holmberg A; Wejstål R; Norkrans G; Cardell K; Weiland O; Lagging M PLoS One; 2013; 8(11):e80172. PubMed ID: 24244641 [TBL] [Abstract][Full Text] [Related]
14. The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients. Mandorfer M; Neukam K; Reiberger T; Payer BA; Rivero A; Puoti M; Boesecke C; Baumgarten A; Grzeszczuk A; Zangerle R; Meyer-Olson D; Rockstroh JK; Trauner M; Pineda JA; Peck-Radosavljevic M AIDS; 2013 Nov; 27(17):2707-14. PubMed ID: 23835502 [TBL] [Abstract][Full Text] [Related]
15. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186 [TBL] [Abstract][Full Text] [Related]
16. Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes. Torres-Cornejo A; Ruiz-Valderas R; Jimenez-Jimenez L; Abad-Molina C; Gutierrez-Valencia A; Viciana P; Lopez-Cortes LF J Viral Hepat; 2014 Mar; 21(3):178-88. PubMed ID: 24438679 [TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients. Corchado S; López-Cortés LF; Rivero-Juárez A; Torres-Cornejo A; Rivero A; Márquez-Coello M; Girón-González JA PLoS One; 2014; 9(7):e101760. PubMed ID: 25013899 [TBL] [Abstract][Full Text] [Related]
18. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients. Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis. Derbala M; Rizk N; Shebl F; Alkaabi S; Eldweik N; John A; Sharma M; Yaqoob R; Almohanadi M; Butt M; Alejji K World J Gastroenterol; 2012 Dec; 18(47):7003-8. PubMed ID: 23323000 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4. De Nicola S; Aghemo A; Rumi MG; Galmozzi E; Valenti L; Soffredini R; De Francesco R; Prati GM; D'Ambrosio R; Cheroni C; Donato MF; Colombo M Hepatology; 2012 Feb; 55(2):336-42. PubMed ID: 21932415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]